Hosted by Damian Doherty, Editor in Chief of Inside Precision Medicine, Inside Precision Medicine Podcasts bring you the latest conversation, insight, and education from the world of precision medicine.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
Epigenetics in the Multi-Omic Era: Predicting Alzheimer’s Before It Starts
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
4 Dec 2025
Transforming Breast Cancer Screening: Lessons from a Landmark Colombian Study
This podcast features George Busby discussing his work on polygenic risk scores (PRS) and their expanding role in precision medicine. He reflects on how he became interested in PRS, recent advances in methylation risk scores (MRS), and the potential of integrating PRS and MRS to improve disease prediction. The conversation highlights his breast cancer study in Colombian women, exploring its hypothesis, findings, and global relevance. Busby also addresses challenges in translating genomic research into clinical practice, efforts to enhance predictive models, and how technological evolution continues to drive innovation and future directions in genomic medicine.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
10 Nov 2025
Methylation Matters: A New Era in Cardiovascular Risk Prediction
This Inside Precision Medicine podcast explores how advances in DNA methylation research are transforming diabetes care. The discussion with Charlotte Ling covers motivations for focusing on methylation as valuable prognosticator of disease, the advantages of methylation risk scores (MRS) compared to polygenic risk scores (PRS), and novel gene associations linked to cardiovascular complications in diabetes. She articulates the validation needs across diverse populations, the influence of lifestyle on methylation stability, and strategies for translating these biomarkers into clinical tools. Finally, she reflects on evolving technologies, future applications of methylation biomarkers, and the potential for precision diagnostics and targeted interventions in high-risk diabetic patients.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
13 Jun 2025
Implementing Tumor Classification in the Lab – Practical Insights and Overcoming Barriers, community engagement
Industry experts discuss implementing DNA methylation-based tumor classification in laboratories, tackling workflow design, operational challenges, and community engagement, offering practical insights for overcoming financial barriers.
22 May 2025
Deep Dive - Advanced Sarcoma and other tumor Applications with Methylation Profiling
Industry experts examine DNA methylation's increasing importance in sarcoma classification and prognosis prediction, focusing on its integration with array, NGS, and CNV analysis for thorough profiling in this interview.
2 May 2025
Expanding Applications and Updates in CNS Tumor Classification Guidelines – from research and boutique to broad clinical application
How DNA methylation changed clinical management of CNS tumors and is being integrated into clinical guidelines, including cIMPACT-NOW updates and the impact of technological advances.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
24 Jul 2024
Tumor Molecular Classifiers Offer Patients New Hope
This IPM podcast highlights the impressive work of Lucas Santana dos Santos, director of bioinformatics and an assistant professor at Northwestern University’s Feinberg School of Medicine. Professor dos Santos discusses the origins and recent developments of molecular tumor classification techniques and how analyzing epigenetic signatures is enabling clinicians to diagnose and treat cancer patients more effectively. This illuminating conversation examines how classifiers are developed and touches on the role of various technologies including the workhorse methylation microarray, in addition to the challenges of creating a universal tumor classifier.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
11 Oct 2023
Precision Psychiatry
This IPM podcast unpacks some of the important work being done by Emma Johnson PhD Assistant Professor | Department of Psychiatry Washington University School of Medicine - we discuss her mission to elucidate the genetic architecture of psychiatric disorders, particularly focusing on substance use and addictions. We hear about her ongoing research in understanding commonly used drugs such as alcohol and cannabis and the relationships between substance use disorders and other psychiatric disorders and mental health conditions, including schizophrenia, suicidal thoughts and behaviors, and chronic pain.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
26 Jul 2023
Pharmacogenetic Testing
In this new Inside Precision Medicine Podcast episode, sponsored by Illumina, we speak with Dr. Julio Monterrey, a Stanford-trained, board-certified psychiatrist and neuroscientist who specializes in diagnosing and treating complex cases. Dr. Monterrey is a keen observer of medical technology who has adopted pharmacogenetic (PGx) testing as a regular part of patient history taking. Through his experience, Dr. Monterrey has seen substantial benefits from PGx testing for his patients and his practice. He is now an advocate for wider adoption of PGx screening to guide and improve patient care. We spoke with Dr. Monterrey to hear what he has learned working with PGx testing in his psychiatry practice.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.
Podcast Authority Score: 1 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
2
Social presence
0
YouTube
0
Engagement
0
Host of Inside Precision Medicine Podcasts?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
